GAPi: A description of the initiative for early psychosis intervention in Latin America and the short- to medium-term outcomes in early psychosis patients.

Autor: Cavalcante DA; Grupo de Atenção às Psicose Iniciais (GAPi), Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil; Centro de Pesquisa e Inovação em Prevenção de Transtornos Mentais e Uso de Álcool e Outras Drogas (CEPIPREV), Health Ministry, Brazil; Laboratório de Neurociências Integrativas (LINC), UNIFESP, Brazil., Noto M; Grupo de Atenção às Psicose Iniciais (GAPi), Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil; Centro de Pesquisa e Inovação em Prevenção de Transtornos Mentais e Uso de Álcool e Outras Drogas (CEPIPREV), Health Ministry, Brazil; Laboratório de Neurociências Integrativas (LINC), UNIFESP, Brazil., Cerqueira RO; Grupo de Atenção às Psicose Iniciais (GAPi), Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil; Centro de Pesquisa e Inovação em Prevenção de Transtornos Mentais e Uso de Álcool e Outras Drogas (CEPIPREV), Health Ministry, Brazil; Laboratório de Neurociências Integrativas (LINC), UNIFESP, Brazil., Costa GO; Grupo de Atenção às Psicose Iniciais (GAPi), Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil; Centro de Pesquisa e Inovação em Prevenção de Transtornos Mentais e Uso de Álcool e Outras Drogas (CEPIPREV), Health Ministry, Brazil; Laboratório de Neurociências Integrativas (LINC), UNIFESP, Brazil; Genetic Division, Department of Morphology and Genetics, UNIFESP, Brazil., Coutinho L; Programa de Esquizofrenia (PROESQ), UNIFESP, Brazil; Laboratório de Neurociências Integrativas (LINC), UNIFESP, Brazil., Malinovski F; Programa de Esquizofrenia (PROESQ), UNIFESP, Brazil; Laboratório de Neurociências Integrativas (LINC), UNIFESP, Brazil., Fonseca AO; Grupo de Atenção às Psicose Iniciais (GAPi), Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil; Centro de Pesquisa e Inovação em Prevenção de Transtornos Mentais e Uso de Álcool e Outras Drogas (CEPIPREV), Health Ministry, Brazil; Programa de Esquizofrenia (PROESQ), UNIFESP, Brazil., Santoro ML; Laboratório de Neurociências Integrativas (LINC), UNIFESP, Brazil; Genetic Division, Department of Morphology and Genetics, UNIFESP, Brazil., Ota V; Laboratório de Neurociências Integrativas (LINC), UNIFESP, Brazil; Genetic Division, Department of Morphology and Genetics, UNIFESP, Brazil., Cordeiro Q; Grupo de Atenção às Psicose Iniciais (GAPi), Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil; Centro de Pesquisa e Inovação em Prevenção de Transtornos Mentais e Uso de Álcool e Outras Drogas (CEPIPREV), Health Ministry, Brazil., Bressan RA; Centro de Pesquisa e Inovação em Prevenção de Transtornos Mentais e Uso de Álcool e Outras Drogas (CEPIPREV), Health Ministry, Brazil; Programa de Esquizofrenia (PROESQ), UNIFESP, Brazil; Laboratório de Neurociências Integrativas (LINC), UNIFESP, Brazil; Instituto Ame Sua Mente, Brazil., Belangero S; Laboratório de Neurociências Integrativas (LINC), UNIFESP, Brazil; Genetic Division, Department of Morphology and Genetics, UNIFESP, Brazil., Gadelha A; Grupo de Atenção às Psicose Iniciais (GAPi), Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil; Centro de Pesquisa e Inovação em Prevenção de Transtornos Mentais e Uso de Álcool e Outras Drogas (CEPIPREV), Health Ministry, Brazil; Programa de Esquizofrenia (PROESQ), UNIFESP, Brazil; Laboratório de Neurociências Integrativas (LINC), UNIFESP, Brazil., Noto C; Grupo de Atenção às Psicose Iniciais (GAPi), Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil; Centro de Pesquisa e Inovação em Prevenção de Transtornos Mentais e Uso de Álcool e Outras Drogas (CEPIPREV), Health Ministry, Brazil; Programa de Esquizofrenia (PROESQ), UNIFESP, Brazil; Laboratório de Neurociências Integrativas (LINC), UNIFESP, Brazil. Electronic address: csnoto@gmail.com.

Publikováno v: Asian journal of psychiatry [Asian J Psychiatr] 2024 Aug; Vol. 98, pp. 104104. Date of Electronic Publication: 2024 Jun 03.

Differences of affective and non-affective psychoses in early intervention services from Latin America.

Autor: Cerqueira RO; Laboratory of Integrative Neuroscience (LiNC), Federal University of Sao Paulo (UNIFESP), Brazil., Ziebold C; Laboratory of Integrative Neuroscience (LiNC), Federal University of Sao Paulo (UNIFESP), Brazil., Cavalcante D; Laboratory of Integrative Neuroscience (LiNC), Federal University of Sao Paulo (UNIFESP), Brazil; Early Psychosis Group (GAPi), Federal University of Sao Paulo (UNIFESP), Brazil., Oliveira G; Genetics Division, Department of Morphology and Genetics, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil., Vásquez J; Department of Psychiatry, Pontificia Universidad Católica de Chile, Santiago, Chile., Undurraga J; Early Intervention Program, Instituto Psiquiátrico Dr J. Horwitz Barak, Santiago, Chile; Department of Neurology and Psychiatry, Faculty of Medicine, Clínica Alemana Universidad del Desarrollo, Santiago, Chile., González-Valderrama A; Early Intervention Program, Instituto Psiquiátrico Dr J. Horwitz Barak, Santiago, Chile., Nachar R; Early Intervention Program, Instituto Psiquiátrico Dr J. Horwitz Barak, Santiago, Chile., Lopez-Jaramillo C; Universidad de Antioquia, Medellin, Colombia., Noto C; Laboratory of Integrative Neuroscience (LiNC), Federal University of Sao Paulo (UNIFESP), Brazil; Early Psychosis Group (GAPi), Federal University of Sao Paulo (UNIFESP), Brazil., Crossley N; Department of Psychiatry, Pontificia Universidad Católica de Chile, Santiago, Chile., Gadelha A; Laboratory of Integrative Neuroscience (LiNC), Federal University of Sao Paulo (UNIFESP), Brazil; Early Psychosis Group (GAPi), Federal University of Sao Paulo (UNIFESP), Brazil. Electronic address: aryararipe@gmail.com.

Publikováno v: Journal of affective disorders [J Affect Disord] 2022 Nov 01; Vol. 316, pp. 83-90. Date of Electronic Publication: 2022 Aug 10.

What not to use in bipolar disorders: A systematic review of non-recommended treatments in clinical practice guidelines.

Autor: Gomes FA; Neurobiology of Mood Disorders Laboratory, Centre for Neuroscience Studies (CNS), Queen's University, 76 Stuart St., Burr 4., Kingston, ON, Canada; Kingston Health Sciences Centre-KGH Site, Kingston, ON, Canada; Department of Psychiatry, Queen's University School of Medicine, Kingston, ON, Canada. Electronic address: fabiano.alvesgomes@queensu.ca., Cerqueira RO; Department of Psychiatry, Federal University of Sao Paulo (Unifesp), Sao Paulo, SP, Brazil., Lee Y; Mood Disorders Psychopharmacology Unit (MDPU), Toronto Western Hospital, University Health Network (UHN), Toronto, ON, Canada; University of Toronto, Toronto, ON, Canada., Mansur RB; Mood Disorders Psychopharmacology Unit (MDPU), Toronto Western Hospital, University Health Network (UHN), Toronto, ON, Canada; University of Toronto, Toronto, ON, Canada., Kapczinski F; Department of Psychiatry and Behavioural Neurosciences and Neuroscience Graduate Program, McMaster University, Hamilton, ON, Canada; Instituto Nacional de Ciência e Tecnologia Translacional em Medicina (INCT-TM), Porto Alegre, RS, Brazil; Bipolar Disorder Program, Laboratory of Molecular Psychiatry, Hospital de Clínicas de Porto Alegre (HCPA), Porto Alegre, RS, Brazil; Department of Psychiatry, Graduate Program in Psychiatry and Behavioral Sciences, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, RS, Brazil., McIntyre RS; Mood Disorders Psychopharmacology Unit (MDPU), Toronto Western Hospital, University Health Network (UHN), Toronto, ON, Canada; University of Toronto, Toronto, ON, Canada., Yatham LN; Department of Psychiatry, University of British Columbia, Vancouver, BC, Canada., Berk M; Deakin University, IMPACT - The Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Barwon Health, Geelong, Australia; Orygen, The National Centre of Excellence in Youth Mental Health, Centre for Youth Mental Health, Florey Institute for Neuroscience and Mental Health and the Department of Psychiatry, The University of Melbourne, Melbourne, Australia., Milev R; Department of Psychiatry, Queen's University School of Medicine, Kingston, ON, Canada; Centre for Neuroscience Studies, Queen's University, Kingston, Canada; Providence Care Hospital, Kingston, Canada., Brietzke E; Neurobiology of Mood Disorders Laboratory, Centre for Neuroscience Studies (CNS), Queen's University, 76 Stuart St., Burr 4., Kingston, ON, Canada; Kingston Health Sciences Centre-KGH Site, Kingston, ON, Canada; Department of Psychiatry, Queen's University School of Medicine, Kingston, ON, Canada.

Publikováno v: Journal of affective disorders [J Affect Disord] 2022 Feb 01; Vol. 298 (Pt A), pp. 565-576. Date of Electronic Publication: 2021 Nov 07.

Barriers to care and psychopathology among Bolivian migrants living in São Paulo, Brazil.

Autor: Ugarte Bustamante LH; Federal University of São Paulo., Cerqueira RO; Federal University of São Paulo., De Marzio F; Federal University of São Paulo., Leite KP; Federal University of São Paulo., Cadurin TDP; Federal University of São Paulo., Leclerc E; Federal University of São Paulo., Vistorte AOR; Federal University of São Paulo., Evans-Lacko S; London School of Economics and Political Science PSSRU., Brietzke E; Federal University of São Paulo.

Publikováno v: Transcultural psychiatry [Transcult Psychiatry] 2020 Feb; Vol. 57 (1), pp. 71-80. Date of Electronic Publication: 2019 Jun 27.

Advances and challenges in development of precision psychiatry through clinical metabolomics on mood and psychotic disorders.

Autor: Pedrini M; Research Group in Molecular and Behavioral Neuroscience of Bipolar Disorder, Federal University of São Paulo, São Paulo, Brazil. Electronic address: marianapedrini@uebel.com.br., Cao B; Mood Disorders Psychopharmacology Unit (MDPU), Toronto Western Hospital, University Health Network (UHN), Toronto, Canada; Department of Laboratorial Science and Technology, School of Public Health, Peking University, Beijing 100191, PR China., Nani JVS; Department of Pharmacology, Escola Paulista de Medicina (EPM), Universidade Federal de São Paulo (UNIFESP), São Paulo, SP, Brazil., Cerqueira RO; Research Group in Molecular and Behavioral Neuroscience of Bipolar Disorder, Federal University of São Paulo, São Paulo, Brazil., Mansur RB; Mood Disorders Psychopharmacology Unit (MDPU), Toronto Western Hospital, University Health Network (UHN), Toronto, Canada., Tasic L; Department of Organic Chemitry, Universidade Estadual de Campinas (UNICAMP), Campinas, SP, Brazil., Hayashi MAF; Department of Pharmacology, Escola Paulista de Medicina (EPM), Universidade Federal de São Paulo (UNIFESP), São Paulo, SP, Brazil., McIntyre RS; Mood Disorders Psychopharmacology Unit (MDPU), Toronto Western Hospital, University Health Network (UHN), Toronto, Canada., Brietzke E; Research Group in Molecular and Behavioral Neuroscience of Bipolar Disorder, Federal University of São Paulo, São Paulo, Brazil; Mood Disorders Psychopharmacology Unit (MDPU), Toronto Western Hospital, University Health Network (UHN), Toronto, Canada. Electronic address: elisabrietzke@hotmail.com.

Publikováno v: Progress in neuro-psychopharmacology & biological psychiatry [Prog Neuropsychopharmacol Biol Psychiatry] 2019 Jul 13; Vol. 93, pp. 182-188. Date of Electronic Publication: 2019 Mar 20.